Uric Acid and Hypertension

Seminars in Nephrology

Volumn 31, Issue 5, 2011, Pages 441-446

  Feig, Daniel I ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Epidemiology; Hypertension; Review; Uric acid; Vascular biology

Indexed keywords

ALLOPURINOL; BENZIODARONE; NITRIC OXIDE; PLACEBO; URIC ACID;

ARTERIOLE; ARTICLE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY BLOOD VESSEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE; URIC ACID BLOOD LEVEL; VASCULAR DISEASE;

ANIMALS; HUMANS; HYPERTENSION; HYPERURICEMIA; URIC ACID;

EID: 80054072712     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.08.008     Document Type: Article

References (68)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
2. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
3. Leenen F.H., Schiffrin E.L. Control rates of hypertension in North America. Hypertension 2010, 56:571-572.
4. Wilkins K., Campbell N.R., Joffres M.R., McAlister F.A., Nichol M., Quach S., et al. Blood pressure in Canadian adults. Health Rep 2010, 21:37-46.
5. Quinn R.R., Hemmelgarn B.R., Padwal R.S., Myers M.G., Cloutier L., Bolli P., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2010, 26:241-248.
6. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(Suppl):555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
7. Mahomed F.A. On chronic Bright's disease, and its essential symptoms. Lancet 1897, 1:399-401.
8. Haig A. On uric acid and arterial tension. Br Med J 1889, 1:288-291.
9. Huchard H. Allgemeine betrachtungen ber die arteriosklerose. Klin Med Berlin 1909, 5:1318-1321.
10. Gertler M.M., Garn S.M., Levine S.A. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951, 34:1421-1431.
11. Breckenridge A. Hypertension and hyperuricaemia. Lancet 1966, 1:15-18.
12. Brand F.N., McGee D.L., Kannel W.B., Stokes J., Castelli W.P. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985, 121:11-18.
13. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
14. Arellano F., Sacristan J.A. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993, 27:337-343.
15. McClintock A.D., Egan A.J., Woods D.J., Pillans P.I. A survey of allopurinol dosage prescribing. N Z Med J 1995, 108:346-347.
16. Nakanishi N., Okamato M., Yoshida H., Matsuo Y., Suzuki K., Tatara K. Serum uric acid and the risk for development of hypertension and imparied fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
17. Taniguchi Y., Hayashi T., Tsumura K., Endo G., Fujii S., Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 2001, 19:1209-1215.
18. Masuo K., Kawaguchi H., Mikami H., Ogihara T., Tuck M.L. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480.
19. Alper A.B., Chen W., Yau L., Srinivasan S.R., Berenson G.S., Hamm L.L. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005, 45:34-38.
20. Sundstrom J., Sullivan L., D'Agostino R.B., Levy D., Kannel W.B., Vasan R.S. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005, 45:28-33.
21. Nefzger M.D., Acheson R.M., Heyman A. Mortality from stroke among U.S. veterans in Georgia and 5 western states. I. Study plan and death rates. J Chronic Dis 1973, 26:393-404.
22. Saito I., Folsom A.R., Brancati F.L., Duncan B.B., Chambless L.E., McGovern P.G. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Ann Intern Med 2000, 133:81-91.
23. Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991, 90:50S-54S.
24. Shankar A., Klein R., Klein B.E., Nieto F.J. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006, 20:937-945.
25. Leite M. Uric acid and fibrinogen: age-modulated relationships with blood pressure components. J Hum Hypertens 2011, 25:476-483.
26. Mazzali M., Hughes J., Kim Y.G., Jefferson J.A., Kang D.H., Gordon K.L., et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38:1101-1106.
27. Watanabe S., Kang D.H., Feng L., Nakagawa T., Kanellis J., Lan H.Y., et al. Uric acid hominoid evolution and the pathogenesis of salt-sensitivity. Hypertension 2002, 40:355-360.
28. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
29. Kang D.H., Park S.K., Lee I.K., Johnson R.J. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16:3553-3562.
30. Mazzali M., Kanellis J., Han L., Feng L., Xia Y.Y., Chen Q., et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002, 282:F991-F997.
31. Rovda Iu I., Kazakova L.M., Plaksina E.A. [Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension]. Pediatriia 1990, 8:19-22.
32. Torok E., Gyarfas I., Csukas M. Factors associated with stable high blood pressure in adolescents. J Hypertens Suppl 1985, 3(Suppl 3):S389-S390.
33. Gruskin A.B. The adolescent with essential hypertension. Am J Kidney Dis 1985, 6:86-90.
34. Feig D.I., Johnson R.J. Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247-252.
35. Feig D.I., Nakagawa T., Karumanchi S.A., Oliver W.J., Kang D.H., Finch J., et al. Hypothesis: uric acid, nephron number and the pathogenesis of essential hypertension. Kidney Int 2004, 66:281-287.
36. Feig D.I., Soletsky B., Johnson R.J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300:924-932.
37. Reyes A.J. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005, 7:461-467.
38. Graessler J., Graessler A., Unger S., Kopprasch S., Tausche A.K., Kuhlisch E., et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006, 54:292-300.
39. Cannella A.C., Mikuls T.R. Understanding treatments for gout. Am J Manag Care 2005, 11(Suppl):S451-S458.
40. Lee S.J., Terkeltaub R.A., Kavenaugh A. Recent developments in diet and gout. Curr Opin Rheumatol 2006, 18:193-198.
41. Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des 2005, 11:4133-4138.
42. Hwang L.C., Tsai C.H., Chen T.H. Overweight and obesity-related metabolic disorders in hospital employees. J Formos Med Assoc 2006, 105:56-63.
43. Pham N.M., Yoshida D., Morita M., Yin G., Toyomura K., Ohnaka K., et al. The relation of coffee consumption to serum uric acid in Japanese men and women aged 49-76 years. J Nutr Metab 2010, 2010. pii: 930757. Epub 2010 Jul 27.
44. Masseoud D., Rott K., Liu-Bryan R., Agudelo C. Overview of hyperuricaemia and gout. Curr Pharm Des 2005, 11:4117-4124.
45. Nakagawa T., Hu H., Zharikov S., Tuttle K.R., Short R.A., Glushakova O., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006, 290:F625-F631.
46. Fox I.H., Kelley W.N. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972, 21:713-721.
47. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
48. Brown C.M., Dulloo A.G., Yepuri G., Montani J.P. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008, 294:R730-R737.
49. Brown C.M., Dulloo A.G., Montani J.P. Sugary drinks in the pathogenesis of obesity and cardiovascular diseases. Int J Obes (Lond) 2008, 32(Suppl 6):S28-S34.
50. Nguyen S., Choi H., Lustig R., Hsu C. The association of sugar sweetened beverage consumption on serum uric acid and blood pressure in a nationally representative sample of adolescents. J Pediatr 2009, 154:807-813.
51. Kahn H.A., Medalie J.H., Neufeld H.N., et al. The incidence of hypertension and associated factors: the Israel ischemic heart study. Am Heart J 1972, 84:171-182.
52. Fessel W.J., Siegelaub A.B., Johnson E.S. Correlates and consequences of asymptomatic hyperuricemia. Arch Intern Med 1973, 132:44-54.
53. Rovda Iu I. [Uric acid and arterial hypertension]. Pediatriia 1992, 10-12:74-78.
54. Selby J.V., Friedman G.D., Quesenberry C.P. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990, 131:1017-1027.
55. Hunt S.C., Stephenson S.H., Hopkins P.N., Williams R.R. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991, 17:969-976.
56. Goldstein H.S., Manowitz P. Relation between serum uric acid and blood pressure in adolescents. Ann Hum Biol 1993, 20:423-431.
57. Jossa F., Farinaro E., Panico S., Krogh V., Celentano E., Galasso R., et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994, 8:677-681.
58. Dyer A.R., Liu K., Walsh M., Kiefe C., Jacobs D.R., Bild D.E. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens 1999, 13:13-21.
59. Imazu M., Yamamoto H., Toyofuku M., Sumii K., Okubo M., Egusa G., et al. Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima study. Hypertens Res 2001, 24:531-536.
60. Nagahama K., Inoue T., Iseki K., Touma T., Kinjo K., Ohya Y., et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004, 27:835-841.
61. Perlstein T.S., Gumieniak O., Williams G.H., Sparrow D., Vokonas P.S., Gaziano M., et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48:1031-1036.
62. Krishnan E., Kwoh C.K., Schumacher H.R., Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007, 49:298-303.
63. Mellen P.B., Bleyer A.J., Erlinger T.P., Evans G.W., Nieto F.J., Wagenknecht L.E., et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the Atherosclerosis Risk in Communities Study. Hypertension 2006, 48:1037-1042.
64. Forman J.P., Choi H., Curhan G.C. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007, 18:287-292.
65. Rathmann W., Haastert B., Icks A., Giani G., Roseman J.M. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol 2007, 22:439-445.
66. Forman J.P., Choi H., Curhan G.C. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009, 169:155-162.
67. Jones D.P., Richey P.A., Alpert B.S. Comparison of ambulatory blood pressure reference standards in children evaluated for hypertension. Blood Press Monit 2009, 14:103-107.
68. Grayson P.C., Kim S.Y., Lavalley M., Choi H.K. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011, 63:102-110.